Daclatasvir, Simeprevir and Ribavirin as a Promising Interferon-Free Triple Regimen for HCV Recurrence after Liver Transplant

Publisher: Karger

E-ISSN: 1421-9867|91|4|326-333

ISSN: 0012-2823

Source: Digestion, Vol.91, Iss.4, 2015-05, pp. : 326-333

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content